Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-04-21

Clinical Trial Update: Efficacy of Riluzole in Hereditary Cerebellar Ataxia [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial investigating the efficacy of riluzole in hereditary cerebellar ataxia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Riluzole (riluzole)

Snippet

Sponsor: S. Andrea Hospital | Conditions: Cerebellar Ataxia | Phase 2, Phase 3 | Status: COMPLETED